BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 554,000 Value ($000) $454 Avg Close — Range —
Q4 2023
Shares 5,709 Value ($000) $4,863 Avg Close — Range —
Q3 2023
Shares 5,709 Value ($000) $4,282 Avg Close — Range —
Q2 2023
Shares 7,269 Value ($000) $4,499 Avg Close — Range —
Q1 2023
Shares 10,544 Value ($000) $6,826 Avg Close — Range —
Q4 2022
Shares 11,048,000 Value ($000) $4,219 Avg Close — Range —
Q3 2022
Shares 11,048,000 Value ($000) $4,902 Avg Close — Range —
Q1 2022
Shares 11,048,000 Value ($000) $5,170 Avg Close — Range —